Can negative lymph node involvement and resection-free margins (ypT1-3N0R0) compete the disease-free survival benefit of a pathologic complete response (ypT0N0R0) in resected pancreatic cancer post neoadjuvant treatment?
APA
Florou E, Zen Y, et al. (2026). Can negative lymph node involvement and resection-free margins (ypT1-3N0R0) compete the disease-free survival benefit of a pathologic complete response (ypT0N0R0) in resected pancreatic cancer post neoadjuvant treatment?. Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.], 26(2), 287-289. https://doi.org/10.1016/j.pan.2025.11.020
MLA
Florou E, et al.. "Can negative lymph node involvement and resection-free margins (ypT1-3N0R0) compete the disease-free survival benefit of a pathologic complete response (ypT0N0R0) in resected pancreatic cancer post neoadjuvant treatment?." Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.], vol. 26, no. 2, 2026, pp. 287-289.
PMID
41350198
같은 제1저자의 인용 많은 논문 (3)
- Polycystic liver disease: Evidence-based management and critical gaps in surgical decision-making.
- Complete pathological response in metastatic pancreatic adenocarcinoma following neoadjuvant therapy.
- Apparent Long-Term Cure Following Conversion Therapy for Initially Unresectable Pancreatic Ductal Adenocarcinoma: A Case Report.